MSD
The company is a global biopharmaceutical leader dedicated to research and development of innovative biologics and cell therapies. The role involves contributing to the development and characterization of biologic therapeutics using advanced molecular interaction techniques in a collaborative, inclusive environment.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD ends takeover talks with Revolution Medicines
1 month ago
Senior Research Associate/Associate Scientist
Xaira Therapeutics
Principal Scientist
Synolo Therapeutics
Research Assistant – Schiffner Lab
The Wistar Institute
Protein Analytics Team Member
Xaira Therapeutics
Scientist I, Biochemistry and Biotherapeutics
PharmaEssentia
Senior Scientist in Centre for Structure & Interactions
Novo Nordisk A/S